239 related articles for article (PubMed ID: 16448798)
1. Downstream processing of oncoretroviral and lentiviral gene therapy vectors.
Segura MM; Kamen A; Garnier A
Biotechnol Adv; 2006; 24(3):321-37. PubMed ID: 16448798
[TBL] [Abstract][Full Text] [Related]
2. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
3. Purification of retrovirus particles using heparin affinity chromatography.
Segura MM; Kamen A; Garnier A
Methods Mol Biol; 2008; 434():1-11. PubMed ID: 18470635
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
Sinn PL; Sauter SL; McCray PB
Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
[TBL] [Abstract][Full Text] [Related]
5. Purification of retroviral vectors for clinical application: biological implications and technological challenges.
Rodrigues T; Carrondo MJ; Alves PM; Cruz PE
J Biotechnol; 2007 Jan; 127(3):520-41. PubMed ID: 16950534
[TBL] [Abstract][Full Text] [Related]
6. Surface-engineering of lentiviral vectors.
Verhoeyen E; Cosset FL
J Gene Med; 2004 Feb; 6 Suppl 1():S83-94. PubMed ID: 14978753
[TBL] [Abstract][Full Text] [Related]
7. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
Neschadim A; McCart JA; Keating A; Medin JA
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral vectors in clinical trials: Current status.
D'Costa J; Mansfield SG; Humeau LM
Curr Opin Mol Ther; 2009 Oct; 11(5):554-64. PubMed ID: 19806504
[TBL] [Abstract][Full Text] [Related]
9. Intracellular trafficking of retroviral vectors: obstacles and advances.
Anderson JL; Hope TJ
Gene Ther; 2005 Dec; 12(23):1667-78. PubMed ID: 16292352
[TBL] [Abstract][Full Text] [Related]
10. Strategies for the isolation and purification of retroviral vectors for gene therapy.
Braas G; Searle PF; Slater NK; Lyddiatt A
Bioseparation; 1996; 6(4):211-28. PubMed ID: 9032984
[TBL] [Abstract][Full Text] [Related]
11. Scaleable purification process for gene therapy retroviral vectors.
Rodrigues T; Carvalho A; Carmo M; Carrondo MJ; Alves PM; Cruz PE
J Gene Med; 2007 Apr; 9(4):233-43. PubMed ID: 17428003
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral vectors: progress and potential.
Lever AM
Curr Opin Mol Ther; 2000 Oct; 2(5):488-96. PubMed ID: 11249751
[TBL] [Abstract][Full Text] [Related]
13. Lentiviruses in gene therapy clinical research.
Connolly JB
Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
Breckpot K; Aerts JL; Thielemans K
Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
[TBL] [Abstract][Full Text] [Related]
15. Large-scale production means for the manufacturing of lentiviral vectors.
Schweizer M; Merten OW
Curr Gene Ther; 2010 Dec; 10(6):474-86. PubMed ID: 21054245
[TBL] [Abstract][Full Text] [Related]
16. Production and purification of lentiviral vectors.
Tiscornia G; Singer O; Verma IM
Nat Protoc; 2006; 1(1):241-5. PubMed ID: 17406239
[TBL] [Abstract][Full Text] [Related]
17. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
[TBL] [Abstract][Full Text] [Related]
18. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography.
Segura MM; Kamen A; Trudel P; Garnier A
Biotechnol Bioeng; 2005 May; 90(4):391-404. PubMed ID: 15812800
[TBL] [Abstract][Full Text] [Related]
19. Lentiviral vectors: are they the future of animal transgenesis?
Park F
Physiol Genomics; 2007 Oct; 31(2):159-73. PubMed ID: 17684037
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral vectors for HIV disease prevention and treatment.
Lemiale F; Korokhov N
Vaccine; 2009 May; 27(25-26):3443-9. PubMed ID: 19201386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
